These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16420754)

  • 1. [Hepatitis C--progress and challenge].
    Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):1-2. PubMed ID: 16420754
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospects for a vaccine against the hepatitis C virus.
    Houghton M; Abrignani S
    Nature; 2005 Aug; 436(7053):961-6. PubMed ID: 16107836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for hepatitis C vaccine.
    Zuckerman AJ; Zuckerman JN
    J Hepatol; 1995; 22(1 Suppl):97-100. PubMed ID: 7602087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
    El-Gogo S; Staib C; Lasarte JJ; Sutter G; Adler H
    J Gene Med; 2008 Feb; 10(2):177-86. PubMed ID: 18076128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis C virus: troublesome vaccination and treatment].
    Carreño V
    Rev Clin Esp; 1993 Mar; 192(4):155-6. PubMed ID: 8386842
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis C vaccine. Current status].
    Forns X
    Gastroenterol Hepatol; 1996; 19(6):317-9. PubMed ID: 8754421
    [No Abstract]   [Full Text] [Related]  

  • 7. Unscrambling hepatitis C virus-host interactions.
    Chisari FV
    Nature; 2005 Aug; 436(7053):930-2. PubMed ID: 16107831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Infection mechanisms of hepatitis C virus].
    Matsuura Y
    Uirusu; 2002 Jun; 52(1):185-90. PubMed ID: 12227171
    [No Abstract]   [Full Text] [Related]  

  • 9. The molecular virology of hepatitis C.
    Major ME; Feinstone SM
    Hepatology; 1997 Jun; 25(6):1527-38. PubMed ID: 9185778
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic diversity of hepatitis C virus: implications for pathogenesis, treatment, and prevention. Report of a meeting of Physicians and Scientists.
    Lancet; 1995 Mar; 345(8949):562-6. PubMed ID: 7776777
    [No Abstract]   [Full Text] [Related]  

  • 11. [The current concepts of viral hepatitis C].
    Gendon IuZ
    Vopr Virusol; 1991; 36(4):268-74. PubMed ID: 1665618
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccines: a moving target.
    Eisenstein M
    Nature; 2011 Jun; 474(7350):S16-7. PubMed ID: 21666730
    [No Abstract]   [Full Text] [Related]  

  • 13. The challenge of developing a vaccine against hepatitis C virus.
    Forns X; Bukh J; Purcell RH
    J Hepatol; 2002 Nov; 37(5):684-95. PubMed ID: 12399239
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current status and strategy of the research on hepatitis C vaccine].
    Nie Q; Li M
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Feb; 19(1):47-9. PubMed ID: 10322709
    [No Abstract]   [Full Text] [Related]  

  • 16. [Present status of developing hepatitis C vaccines].
    Arakawa Y; Moriyama M; Shikata T
    Nihon Naika Gakkai Zasshi; 1994 Feb; 83(2):245-51. PubMed ID: 7525800
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccination against hepatitis B and C: towards therapeutic application.
    Inchauspe G; Bach G; Martin P; Bonnefoy JY
    Int Rev Immunol; 2009; 28(1):7-19. PubMed ID: 19241251
    [No Abstract]   [Full Text] [Related]  

  • 18. [Induction of cytotoxic T cell responses in mice by immunization with multi-CTL epitope-based anti-HCV DNA vaccine].
    Shi L; Liu S; Sheng L; Meng ZJ; Yuan YK
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):385-6. PubMed ID: 16732921
    [No Abstract]   [Full Text] [Related]  

  • 19. Exploiting information inherent in binding sites of virus-specific antibodies: design of an HCV vaccine candidate cross-reactive with multiple genotypes.
    Grollo L; Torresi J; Drummer H; Zeng W; Williamson N; Jackson DC
    Antivir Ther; 2006; 11(8):1005-14. PubMed ID: 17302370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons from Nature: Understanding Immunity to HCV to Guide Vaccine Design.
    Freeman ZT; Cox AL
    PLoS Pathog; 2016 Jun; 12(6):e1005632. PubMed ID: 27362419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.